Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
1 |
Aho VV et al. |
Group II phospholipase A2 content of tears in patients with senile cataract and primary open-angle glaucoma.
|
2 |
Aho VV et al. |
Group IIA phospholipase A2 content of tears in patients with keratoconjunctivitis sicca.
|
3 |
Aho VV et al. |
Group IIA phospholipase A2 content of basal, nonstimulated and reflex tears.
|
4 |
Huoponen K et al. |
Genetic counseling in Leber hereditary optic neuropathy (LHON).
|
5 |
Ihanamäki T. |
A transgenic mouse model for human arthro-ophthalmopathies. A cell and molecular biologic, histologic, ultrastructural and immunohistochemical characterization of ocular abnormalities in transgenic mice with type II collagen gene mutations.
|
6 |
Kampik A et al. |
Intraocular pressure-lowering effects of latanoprost and brimonidine therapy in patients with open-angle glaucoma or ocular hypertension: A randomized observer-masked multicenter study.
|
7 |
Korte J-M et al. |
Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops.
|
8 |
Pihlajamäki M et al. |
Ribosomal mutations in streptococcus pneumoniae clinical isolates.
|
9 |
Puomila A et al. |
Segregation of the ND4/11778 and the ND1/3460 mutations in four heteroplasmic LHON families.
|
10 |
Saari JM et al. |
Pseudomonas aeruginosa keratitis: resolution after debridement.
|
11 |
Saari KM et al. |
Neodymium:YAG laser surgery in the hospital district of southwestern Finland during the years 1987 to 1998.
|
12 |
Tuomaala S et al. |
Corneally displaced malignant conjunctival melanomas.
|
13 |
Vainio-Jylhä E et al. |
Progression of retinal nerve fibre layer damage in betaxolol- and timolol-treated glaucoma patients.
|